Workflow
US FDA adds boxed warning to J&J, Legend Biotech's cancer therapy
Reutersยท2025-10-10 22:36

Core Viewpoint - The U.S. Food and Drug Administration has approved labeling changes for Johnson & Johnson and Legend Biotech's blood cancer therapy, which now includes a boxed warning for a potentially fatal side effect [1] Group 1 - The FDA's approval indicates a significant regulatory update for the blood cancer therapy developed by Johnson & Johnson and Legend Biotech [1] - The inclusion of a boxed warning highlights the seriousness of the potential side effects associated with the therapy, which may impact its market perception and usage [1]